Published in Bibl Haematol on January 01, 1975
Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science (1986) 8.15
Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Natl Cancer Inst (1970) 3.94
Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature (1978) 3.73
A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection. Ann Intern Med (1992) 3.42
In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6). J Exp Med (1988) 2.81
HBLV (or HHV-6) in human cell lines. Nature (1987) 2.53
Genomic analysis of the human B-lymphotropic virus (HBLV). Science (1986) 2.23
Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6. Nature (1989) 1.96
Nasopharyngeal carcinoma. X. Presence of epstein-barr genomes in separated epithelial cells of tumours in patients from Singapore, Tunisia and Kenya. Int J Cancer (1975) 1.95
Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus. Proc Natl Acad Sci U S A (1992) 1.85
Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type I: a clinical and seroepidemiological study of 25 cases. Ann Neurol (1987) 1.63
Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion (2003) 1.47
Clinical, epidemiologic, and virologic studies in four clusters of the chronic fatigue syndrome. Arch Intern Med (1992) 1.46
Histopathology of nasopharyngeal carcinoma: correlations with epidemiology, survival rates and other biological characteristics. Cancer (1979) 1.44
Lymphoblastoid transformation and presence of herpes-type viral particles in a Chinese nasopharyngeal tumour cultured in vitro. Nature (1969) 1.36
Nasopharyngeal carcinoma. IX. Antibodies to EBNA and correlation with response to other ebv antigens in chinese patients. Int J Cancer (1975) 1.35
Antibody reactions to herpesvirus saimiri (HVS)-induced early and late antigens (EA and LA) in HVS-infected squirrel, marmoset and owl monkeys. Int J Cancer (1973) 1.34
Molecular studies of HHV-6. J Virol Methods (1988) 1.32
The relationship between nasopharyngeal carcinoma and the HL-A system among Tunisians. Int J Cancer (1975) 1.30
Diverse tropism of HBLV (human herpesvirus 6) Lancet (1987) 1.29
Elevated antibody titers to Epstein-Barr virus in Hodgkin's disease. Cancer (1971) 1.25
Epidemiologic features of rapidly progressing breast cancer in Tunisia. Cancer (1980) 1.24
The spectrum of clinical and laboratory findings resulting from human herpesvirus-6 (HHV-6) in patients with mononucleosis-like illnesses not resulting from Epstein-Barr virus or cytomegalovirus. Am J Clin Pathol (1990) 1.23
Lymphoblastoid transformation and kinetics of appearance of viral nuclear antigen (EBNA) in cord-blood lymphocytes infected by Epstein-Barr Virus (EBV). Int J Cancer (1975) 1.23
Human herpesvirus 7 (HHV-7) strain JI: independent confirmation of HHV-7. J Infect Dis (1992) 1.22
Antigenic relationships among human herpesvirus-6 isolates. J Med Virol (1992) 1.18
Detection of human B-lymphotropic virus (human herpesvirus 6) sequences in B cell lymphoma tissues of three patients. Leukemia (1988) 1.17
HTLV-I and tropical spastic paraparesis in Africa. Lancet (1986) 1.17
Identification of the human herpesvirus 6 glycoprotein H and putative large tegument protein genes. J Virol (1991) 1.17
Preparation of immune rabbit sera with neutralizing activity against human cytomegalovirus and varicella-zoster virus. J Gen Virol (1970) 1.15
Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome. Clin Infect Dis (1994) 1.14
Seroepidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV). Semin Cancer Biol (1999) 1.14
Immunogenetic aspects of nasopharyngeal carcinoma. IV. Increased risk in Chinese of nasopharyngeal carcinoma associated with a Chinese-related HLA profile (A2, Singapore 2). J Natl Cancer Inst (1976) 1.13
Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures. J Virol (1991) 1.11
Volatile nitrosamine levels in common foods from Tunisia, south China and Greenland, high-risk areas for nasopharyngeal carcinoma (NPC). Int J Cancer (1987) 1.11
Detection of anti-Epstein-Barr-virus transactivator (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinoma. Int J Cancer (1991) 1.11
Prognostic value of EBV markers in the clinical management of nasopharyngeal carcinoma (NPC): a multicenter follow-up study. Int J Cancer (1988) 1.09
Modulatory effects of Epstein-Barr, herpes simplex, and human herpes-6 viral infections and coinfections on cytokine synthesis. A comparative study. J Immunol (1992) 1.09
Clinical and prognostic features of a rapidly progressing breast cancer in Tunisia. Cancer (1977) 1.08
Malignant lymphoma with lymphocytic leukemia induced in owl monkeys by Herpesvirus saimiri. J Natl Cancer Inst (1971) 1.08
Treatment of alpha chain disease. Results of a prospective study in 21 Tunisian patients by the Tunisian-French intestinal Lymphoma Study Group. Cancer (1989) 1.07
HTLV-III infection of EBV-genome-positive B-lymphoid cells with or without detectable T4 antigens. Int J Cancer (1987) 1.07
Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6. J Virol (1993) 1.06
HHV-6 reactivation in chronic fatigue syndrome. Lancet (1991) 1.06
Diet, living conditions and nasopharyngeal carcinoma in Tunisia--a case-control study. Int J Cancer (1990) 1.06
Nasopharyngeal carcinoma (NPC). I. Types of cultures derived from tumour biopsies and non-tumorous tissues of Chinese patients with special reference to lymphoblastoid transformation. Int J Cancer (1970) 1.06
A repeat sequence, GGGTTA, is shared by DNA of human herpesvirus 6 and Marek's disease virus. J Virol (1988) 1.05
Human herpesvirus 6 (HHV6) and chronic fatigue syndrome (CFS). Can Dis Wkly Rep (1991) 1.05
Latent herpesvirus-6 in salivary and bronchial glands. Lancet (1990) 1.03
Sero-epidemiology of the Epstein-Barr virus: preliminary analysis of an international study - a review. IARC Sci Publ (1975) 1.03
HTLV-I, brain abnormalities on magnetic resonance imaging, and relation with multiple sclerosis. Lancet (1987) 1.02
Roles of Lignin Peroxidase and Manganese Peroxidase from Phanerochaete chrysosporium in the Decolorization of Olive Mill Wastewaters. Appl Environ Microbiol (1995) 1.02
Differentiation of cross-reacting simian cytomegalovirus strains by late 19S rabbit neutralizing antibodies. J Immunol (1969) 1.02
Intrathecal synthesis of antibodies to human T lymphotropic virus type I and the presence of IgG oligoclonal bands in the cerebrospinal fluid of patients with endemic tropical spastic paraparesis. J Infect Dis (1988) 1.01
Human herpesvirus 6 infects cervical epithelial cells and transactivates human papillomavirus gene expression. J Virol (1994) 1.00
[Biosynthesis of the lateral ethyl chain of stigmastanol and of stigmasten-22, o1-3beta in the myxomycete Dictyostelium discoideum]. Eur J Biochem (1971) 1.00
Antibody prevalence to HBLV (human herpesvirus-6, HHV-6) and suggestive pathogenicity in the general population and in patients with immune deficiency syndromes. J Virol Methods (1988) 0.99
Regression of oral hairy leukoplakia after orally administered acyclovir therapy. JAMA (1988) 0.98
Epstein-Barr virus and Burkitt's lymphoma worldwide: the causal relationship revisited. IARC Sci Publ (1985) 0.97
Comparison of zymogram of three lymphoblastoid cell lines with a new microtechnique. Biomedicine (1976) 0.94
Murine cytomegalovirus: induction of and sensitivity to interferon in vitro. Infect Immun (1975) 0.93
Cellular immunity in infectious mononucleosis. II. Specific reactivity to Epstein-Barr Virus antigens and correlation with clinical and hematologic parameters. J Immunol (1978) 0.92
Comparative seroepidemiology of HTLV-I and HTLV-III in the French West Indies and some African countries. Cancer Res (1985) 0.92
Preparation of rabbit immune serum with neutralizing activity against a simian cytomegalovirus (SA6). J Immunol (1969) 0.92
Human B-lymphotropic virus in Germany. Lancet (1987) 0.92
Morphological studies on Herpesvirus saimiri in subhuman and human cell cultures. Cancer Res (1971) 0.92
Presence of EBV-DNA sequences in nasopharyngeal cells of individuals without IgA-VCA antibodies. Int J Cancer (1983) 0.91
Immunogenetic aspects of nasopharyngeal carcinoma (NPC) III. HL-a type as a genetic marker of NPC predisposition to test the hypothesis that Epstein-Barr virus is an etiological factor in NPC. IARC Sci Publ (1975) 0.91
Mixed culture cytopathogenicity induced by virus preparations derived from cultures infected by simian sarcoma virus. J Natl Cancer Inst (1972) 0.91
Breast cancer in women under 30 years of age. Breast Cancer Res Treat (1985) 0.91
Expression of HLA-DR antigens in nasopharyngeal carcinoma: an immunohistological analysis of the tumour cells and infiltrating lymphocytes. Int J Cancer (1984) 0.90
Mediterranean lymphomas with alpha heavy chain monoclonal gammopathy. Cancer (1976) 0.90
Epidemiology and immunovirology of human T-cell leukemia/lymphoma virus type I-associated adult T-cell leukemia and chronic myelopathies as seen in France. Cancer Res (1990) 0.90
Tumors of the nasopharynx in Tunisia. An anatomic and clinical study based on 143 cases. Cancer (1974) 0.89
[On the biosynthesis of the ethyl side chain of sterols by the Myxomycete Dictostelium discoileum]. Eur J Biochem (1969) 0.89
Effects of 5-tungsto-2-antimoniate in oncogenic DNA and RNA virus-cell systems. Eur J Cancer (1977) 0.89
The Inoue-Melnick virus, human herpesvirus type 6, and the chronic fatigue syndrome. Ann Intern Med (1989) 0.89
Infection of rats with human T-cell leukemia virus type-I: susceptibility of inbred strains, antibody response and provirus location. Int J Cancer (1994) 0.89
Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: variable frequencies found in a multicenter serological study. J Med Virol (2000) 0.89
Oncogenic herpesviruses of nonhuman primates. Comp Immunol Microbiol Infect Dis (1979) 0.89
Human herpesvirus type 8 in salivary gland tumors. J Clin Virol (2000) 0.88
Experimental infection of Callithrix Jacchus marmosets with Herpesvirus ateles, Herpesvirus saimiri, and Epstein Barr virus. Biomedicine (1978) 0.88
Active human herpesvirus-6 (HHV-6) infection associated with Kikuchi-Fujimoto disease and systemic lupus erythematosus (SLE). In Vivo (1991) 0.88
Characteristics of Herpesvirus saimiri-induced lymphoma cells in tissue culture. In Vitro (1974) 0.88
Nasopharyngeal carcinoma in children and adolescents in Tunisia: clinical aspects and the paraneoplastic syndrome. IARC Sci Publ (1978) 0.87
Persistent active herpes virus infection associated with atypical polyclonal lymphoproliferation (APL) and malignant lymphoma. Anticancer Res (1990) 0.87
In vitro transforming activity of EBV. I-Establishment and properties of two EBV strains (M81 and M72) produced by immortalized Callithrix jacchus lymphocytes. Biomedicine (1976) 0.87
In vitro inhibition of human herpesvirus-6 by phosphonoformate. J Virol Methods (1988) 0.87
Human herpesvirus-6 and cross-reactivity with other herpesviruses. Lancet (1989) 0.86
HTLV antibodies in patients with non-Hodgkin lymphomas in Martinique. Lancet (1984) 0.86
Studies on the role of cellular immunity and genetics in the etiology of rapidly progressing breast cancer in Tunisia. Int J Cancer (1981) 0.86
Epstein-Barr virus and Herpesvirus saimiri: sensitivity to interferons and interferon inducers. J Natl Cancer Inst (1981) 0.86
Increased incidence of mouse mammary tumor virus-related antigen in Tunisian patients with breast cancer. Int J Cancer (1984) 0.86